Pfizer might be able to identify potential safety issues of drug candidates in early stages, as it has licensed a human cell line from Absorption Systems designed to do just that. What Pfizer has an ...

Comprehensive Analysis Examines Liposomal NMN Delivery, Dosage Research Context, Third-Party Verification Standards, and What Distinguishes GenuinePurity's NAD+ Precursor Formulation in an Expanding ...

Researchers have elucidated the relationship between the photocurrent and the peculiar changes in the absorption structure occurring in the vicinity of the molecular-electrode interface in ...

SAN FRANCISCO, CA, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare ...